Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
!!T3 ROPIVACAINE HYDROCHLORIDE INJECTION, USP FRESENIUS KABI CANADA LTD Actual shortage 10MG Updated Report 2025-12-08 257455
ETOMIDATE INJECTION, USP FRESENIUS KABI CANADA LTD Anticipated shortage 2MG Updated Report 2025-12-08 273806
ROCURONIUM BROMIDE INJECTION JUNO PHARMACEUTICALS CORP. Anticipated shortage 10MG New Report 2025-12-08 273803
TOBI PODHALER BGP PHARMA ULC Anticipated shortage 28MG Updated Report 2025-12-08 271073
DETROL LA BGP PHARMA ULC Actual shortage 2MG Updated Report 2025-12-08 272149
DILANTIN BGP PHARMA ULC Actual shortage 100MG Updated Report 2025-12-08 269465
DETROL BGP PHARMA ULC Anticipated shortage 1MG New Report 2025-12-08 273794
MYLAN-PROPAFENONE MYLAN PHARMACEUTICALS ULC Anticipated shortage 300MG Updated Report 2025-12-08 271408
MYLAN-ALMOTRIPTAN MYLAN PHARMACEUTICALS ULC Anticipated shortage 12.5MG New Report 2025-12-08 273789
MYL-ESOMEPRAZOLE MYLAN PHARMACEUTICALS ULC Anticipated shortage 20MG New Report 2025-12-08 273786

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
FIASP NOVO NORDISK CANADA INC Discontinued 100UNIT Updated Report 2025-12-08 240240
TRUSOPT ELVIUM LIFE SCIENCES To be discontinued 2% Updated Report 2025-12-08 267941
NAT-LEVETIRACETAM NATCO PHARMA (CANADA) INC Discontinued 500MG Updated Report 2025-12-06 273434
NAT-LEVETIRACETAM NATCO PHARMA (CANADA) INC Discontinued 750MG Updated Report 2025-12-06 273437
NAT-OMEPRAZOLE DR NATCO PHARMA (CANADA) INC Discontinued 20MG Updated Report 2025-12-06 273440